P21 upregulation in response to PAK6 knockdown also contradicts previous findings in prostate cancer cells, where PAK6 knockdown induced expression of cyclin D1, a proliferation marker negatively regulated by p21, enhancing tumor growth in vitro and in vivo [30]. Here, PAK6 is linked to prostate carcinoma.